RBC Capital analyst Gregory Renza ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Acadia Pharmaceuticals (ACAD) PT Lowered to $39 at Mizuho, 'Daybue Seasonality Trend May Raise Concerns'February 28, 2024 6:15 AM